Research Frontiers Incorporated REFR

0.79 0.05 6.76% as of 25 Sep
Market cap
$26.2M
P/E
0.0×
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(87.35%) (115.64%) (113.70%) (154.03%)
ROA
(65.46%) (65.03%) (69.89%) (79.66%)
ROIC
(335.77%) (494.82%) (300.46%) (4,055.56%)
Return on Tangible Assets
(133.97%) (240.83%) (140.48%) (214.75%)
Average Days of Receivables
110.60 133.05 285.12 116.07
Free Cash Flow per Share
(0.02) (0.04) (0.04) (0.04)
Free Cash Flow
(0.82) (1.33) (1.45) (1.56)
Capital Expenditures
0.00 0.00 0.00 0.00
Piotroski F-Score
2.00 2.00 1.00 1.00
Other line items
Cash ROIC
(31.03%) (83.18%) (47.27%) (70.58%)
Accounts Receivable Turnover
1.73 2.10 0.92 1.76
Accounts Payable Turnover
81.27 24.21 44.22 29.83
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
4.12 18.31 14.59 20.73
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
51.65% 54.29% 84.74% 84.24%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Share Based Compensation of Revenue
33.34% 41.40% 0.00% 0.00%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.43 0.65 0.60 0.69
Depreciation/Fixed assets
43.23 54.91 59.48 62.62
Capex/Depreciation
(0.01) 0.00 0.00 0.00
Revenue per Share
0.04 0.03 0.02 0.02
Operating CF per Share
(0.02) (0.04) (0.04) (0.04)
Capex per Share
0.00 0.00 0.00 0.00
Capex to Sales
0.00 0.00 0.00 0.00
Net Profit Margin
(153.83%) (182.45%) (343.03%) (343.94%)

Fold the line items

Columns are period end dates